Similar articles

• [Doxepin hydrochloride. Clinical value of this new thymoanaleptic agent].

  Richou H, Hug R. Richou H, et al. Nouv Presse Med. 1972 Jun 17;1(25):1717-8. Nouv Presse Med. 1972. PMID: 5041723 French. No abstract available.
• [Use of Doxepin hydrochloride in the treatment of depression].

  Prévia N. Prévia N. J Bras Psiquiatr. 1970 Jan-Jun;19(1):111-5. J Bras Psiquiatr. 1970. PMID: 4949102 Clinical Trial. Spanish. No abstract available.
• [Comparative evaluation of antidepressive-anxiolytic substances, with special references to Doxepin (Sinquan), a diphenylmethane derivative].

  Terzani S. Terzani S. Schweiz Arch Neurol Neurochir Psychiatr. 1972;110(1):169-82. Schweiz Arch Neurol Neurochir Psychiatr. 1972. PMID: 5028388 German. No abstract available.
• The use of doxepin in the treatment of symptoms of anxiety neurosis and accompanying depression: a collaborative controlled study.

  Goldberg HL, Finnery RJ. Goldberg HL, et al. Am J Psychiatry. 1972 Jul;129(1):74-7. doi: 10.1176/ajp.129.1.74. Am J Psychiatry. 1972. PMID: 4556088 Clinical Trial. No abstract available.
• Treatment of the depressive reaction: a clinical evaluation of a new psychotherapeutic drug, Doxepin (Sinequan).

  Gillmer RE. Gillmer RE. S Afr Med J. 1970 Dec 12;44(48):1386-8. S Afr Med J. 1970. PMID: 5515515 No abstract available.